← All trials
NCT06895811
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 27, 2025
- Primary completion
- Nov 30, 2025
- Completion date
- Nov 30, 2025
- First posted
- Mar 26, 2025
- Last posted
- Apr 11, 2025
- Enrollment
- 3
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Second Military Medical UniversityLead sponsor
- Second Military Medical UniversitySponsor investigator
- Shanghai Bioray Laboratory Inc.Collaborator
- Second Military Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.